Daily Ards Research Analysis
Three impactful ARDS studies emerged today: a PROSPERO-registered meta-analysis proposes a practical driving pressure threshold (~15 cm H2O) for ECMO initiation; a porcine ARDS experiment reveals prone positioning may impair renal perfusion and promote glomerular thrombosis; and a mechanistic study shows CGRP mitigates LPS-induced lung injury by rebalancing macrophage polarization via HIF-1α inhibition.
Summary
Three impactful ARDS studies emerged today: a PROSPERO-registered meta-analysis proposes a practical driving pressure threshold (~15 cm H2O) for ECMO initiation; a porcine ARDS experiment reveals prone positioning may impair renal perfusion and promote glomerular thrombosis; and a mechanistic study shows CGRP mitigates LPS-induced lung injury by rebalancing macrophage polarization via HIF-1α inhibition.
Research Themes
- ECMO initiation thresholds and ventilatory mechanics in severe ARDS
- Organ cross-talk and renal risk during prone positioning
- Neuropeptide-driven immunomodulation (CGRP–HIF-1α) in ARDS inflammation
Selected Articles
1. Prognostic Significance of Driving Pressure for Initiation and Maintenance of ECMO in Patients with Severe ARDS: A Systematic Review and Meta-analysis.
Across six studies (n=668), survivors had lower driving pressure at ECMO initiation. The pooled analysis supports an operational threshold of approximately 15 cm H2O for initiating ECMO in severe ARDS on mechanical ventilation.
Impact: Provides an actionable, physiology-based threshold to guide timing of ECMO initiation in severe ARDS, a decision point with major prognostic implications.
Clinical Implications: Consider initiating ECMO when driving pressure approaches/exceeds ~15 cm H2O despite optimal lung-protective ventilation, and monitor DP trajectories during ECMO.
Key Findings
- Survivors had lower driving pressure at ECMO initiation across pooled data.
- An approximate 15 cm H2O driving pressure threshold is supported for ECMO initiation in severe ARDS.
- Six studies (668 patients) were synthesized with registered protocol (PROSPERO CRD42022327846).
Methodological Strengths
- PROSPERO-registered protocol and multi-database search
- Independent dual-reviewer screening and data extraction
Limitations
- Evidence synthesized largely from observational studies rather than RCTs
- Potential heterogeneity in ventilator settings and DP measurement across studies
Future Directions: Prospective validation of DP thresholds and randomized trials testing DP-guided ECMO initiation strategies.
INTRODUCTION: In life-threatening conditions like severe acute respiratory distress syndrome (ARDS), rescue interventions like extracorporeal membrane oxygenation (ECMO) should be initiated urgently to resolve an otherwise potentially adverse clinical outcome. Driving pressure (DP) is an independent prognosticator of the survival of ARDS during mechanical ventilation. We conducted this review with the objective to identify the optimal DP for initiating ECMO in severe ARDS and to study the change in DP during ECMO strategy in survivors and non-survivors. MATERIALS AND METHODS: A systematic search of EMBASE, PubMed, Cochrane Library, and SCOPUS databases was conducted from their inception to January 2024. Two investigators independently carried out the processes of literature search, study selection, data extraction, and quality assessment. The analysis was conducted using comprehensive meta-analysis software (CMA). RESULTS: For meta-analysis, six studies comprising 668 patients were included. In survivors, the DP at ECMO initiation was lower (mean DP = 14.56 cm H CONCLUSION: The optimum DP to initiate ECMO in severe ARDS patients on MV is 15 cm H TRIAL REGISTRATION: PROSPERO CRD42022327846. HOW TO CITE THIS ARTICLE: Todur P, Nileshwar A, Chaudhuri S, Nagendra D, Shanbhag V, Vennila J. Prognostic Significance of Driving Pressure for Initiation and Maintenance of ECMO in Patients with Severe ARDS: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2025;29(2):177-185.
2. CGRP alleviates lipopolysaccharide-induced ARDS inflammation via the HIF-1α signaling pathway.
CGRP levels are elevated in ARDS and the peptide mitigates LPS-induced lung injury by shifting macrophage polarization (↓M1, ↑M2) via its receptor RAMP1. Transcriptomics implicate HIF-1α; CGRP alleviates pathological injury, inflammation, and oxidative stress by inhibiting the HIF-1α pathway.
Impact: Reveals a neuroimmune mechanism (CGRP–HIF-1α) regulating macrophage polarization in ARDS and identifies a druggable pathway with translational promise.
Clinical Implications: Supports exploration of CGRP pathway modulators to treat ARDS-related inflammatory surges and guides biomarker-driven strategies focused on macrophage polarization and HIF-1α.
Key Findings
- CGRP expression is increased in ARDS patient serum and in vitro/in vivo ARDS models.
- CGRP, via RAMP1, decreases M1 and increases M2 macrophages, reducing injury, inflammation, oxidative stress, and apoptosis in LPS-induced ARDS.
- Transcriptomics implicate HIF-1α; CGRP alleviates damage by inhibiting the HIF-1α pathway.
Methodological Strengths
- Multi-system validation: patient serum, in vitro, and in vivo models
- Mechanistic dissection with transcriptome profiling and receptor-target (RAMP1) interrogation
Limitations
- Preclinical nature limits direct clinical generalizability
- Model primarily based on LPS-induced injury; human interventional data lacking
Future Directions: Evaluate CGRP agonists/antagonists and HIF-1α modulators in clinically relevant ARDS models and early-phase human trials with macrophage polarization biomarkers.
Acute respiratory distress syndrome (ARDS) is an acute and severe disease with a high mortality rate. The outbreak of immune inflammation in the lung is an important pathogenic mechanism of ARDS. Notably, an imbalance in macrophage polarization is an important link in the occurrence and development of this inflammatory response. Recently, neuropeptides have been shown to regulate inflammation, but the role of neuropeptides in ARDS remains unclear. The aim of this study was to investigate the regulatory effect of calcitonin gene-related peptide (CGRP) on the inflammatory response in ARDS. We found that CGRP expression was increased in the serum of ARDS patients and in both in vitro and in vivo models of ARDS. CGRP can regulate the polarization of macrophages by targeting its receptor (receptor activity-modifying protein 1); reduce the proportion of M1 macrophages; increase the proportion of M2 macrophages; and reduce pathological injury, inflammation, oxidative stress, and apoptosis in lung tissue in LPS-induced ARDS both in vitro and in vivo. Additionally, we performed transcriptome sequencing and found that hypoxia-inducible factor-1α (HIF-1α) is involved in the above process and that CGRP can alleviate ARDS-related pathological damage, inflammation, and oxidative stress by inhibiting the HIF-1α pathway to regulate macrophage polarization balance. These results indicate that CGRP has good potential for clinical translation in the treatment of pulmonary infection in ARDS. Furthermore, this study provides new ideas for the treatment of inflammatory bursts in ARDS.
3. Enhanced glomerular thrombosis in pronated animals with ARDS.
In a randomized porcine ARDS model, prone positioning was linked to enhanced glomerular thrombosis and reduced renal perfusion, assessed by multimodal PET-MRI and tissue analyses. Findings highlight potential renal risks of pronation despite known pulmonary benefits.
Impact: Challenges the assumption that prone positioning is uniformly benign by revealing renal microvascular consequences in ARDS.
Clinical Implications: During proning in ARDS, intensify renal monitoring and consider anticoagulation and hemodynamic strategies to mitigate renal hypoperfusion and microthrombosis risk.
Key Findings
- Prone positioning was associated with enhanced glomerular thrombosis in a porcine ARDS model.
- Renal perfusion was lower in pronated animals, assessed by PET-MRI and tissue analyses.
Methodological Strengths
- Randomized allocation to prone vs supine positioning
- Multimodal assessment including PET-MRI, histopathology, and cytokine profiling
Limitations
- Small sample size and short (6-hour) observation period
- Animal model findings may not directly generalize to human ARDS
Future Directions: Prospective clinical studies to quantify renal perfusion/thrombosis during proning and to test protective anticoagulation or positioning strategies.
BACKGROUND: Prone positioning is part of the management of acute respiratory distress syndrome (ARDS) and has been demonstrated to successfully improve the ventilation-perfusion match and reduce mortality in patients with severe respiratory failure. However, the effect of pronation on other organs than the lungs has not been widely studied. This study aimed to compare abdominal edema, perfusion and inflammation in supine and prone positioning in a porcine ARDS model. METHODS: Seventeen piglets were randomized into two groups: a supine group (n = 9) and a prone group (n = 8). Both groups received endotoxemic infusion and were observed for 6 h. Three animals per group underwent positron emission tomography-magnetic resonance imaging (PET-MRI) for imaging acquisition. Hemodynamic and respiratory parameters were recorded throughout the protocol. Inflammation was assessed by measuring cytokine concentrations in blood, ascites and the abdominal organs' tissue. The edema in abdominal organs was assessed by wet-dry ratio and pathophysiological analysis of tissue samples and by MRI and PET measurements from volumes of interest (VOIs) delineated in abdominal organ in MRI and PET images. The abdominal organs' perfusion was also assessed by MRI and PET measurements. RESULTS: The prone group had a faster CO CONCLUSIONS: In a porcine ARDS model, prone positioning was associated with enhanced glomerular thrombosis and low renal perfusion.